Sensible Medical Innovations
Netanya, Israel· Est.
Sensible Medical delivers a rapid, non‑invasive lung‑fluid sensor to transform heart‑failure monitoring and cut hospital readmissions.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Sensible Medical delivers a rapid, non‑invasive lung‑fluid sensor to transform heart‑failure monitoring and cut hospital readmissions.
Heart Failure
Technology Platform
Remote Dielectric Sensing (ReDS) – a non‑invasive, bedside technology that quantifies lung fluid volume in seconds using dielectric properties of tissue.
Opportunities
Expansion into remote monitoring platforms and broader fluid‑management indications can drive substantial revenue growth.
Risk Factors
Reimbursement uncertainty and competition from emerging bio‑impedance and ultrasound technologies could limit market penetration.
Competitive Landscape
Key competitors include ultrasound‑based lung‑fluid sensors and bio‑impedance devices, but Sensible Medical’s rapid, non‑invasive ReDS technology and robust clinical data provide a clear differentiation.